Company / Current Liabilities per Share
REGENXBIO Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.38
FY2025
5-year range
$2.34 / $3.48
FY2021-FY2025
Trend
+1.7%
vs FY2024
Sector context
#62 of 210
Health Care
What the data says
At $2.38, REGENXBIO Inc.'s current liabilities per share ranks #149 of 210 in the Health Care sector. Current Liabilities per Share returned to growth in FY2025 after 3 years of decline, reaching $2.38.
Based on SEC 10-K filings.
2.38 in FY2025 with a 5-year CAGR of +1.6%.
Improved from $3.01 to $2.38 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
#149 of 210 in Health CareTop 70% of 210This company $2.38 Sector average $15.78
▼
-84.9% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 1.7% year-over-year.
- Ranks #62 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2021.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.38 | +1.7% |
| FY2024 | $2.34 | -22.1% |
| FY2023 | $3.01 | -1.2% |
| FY2022 | $3.05 | -12.5% |
| FY2021 | $3.48 | +58.1% |
| FY2020 | $2.20 | +136.2% |
| FY2019 | $0.93 | +31.6% |
| FY2018 | $0.71 | +30.0% |
| FY2017 | $0.55 | +48.4% |
| FY2016 | $0.37 | -77.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026